Axogen Completes Acquisition of BioCircuit Technologies, Adding Sutureless Nerve Repair Device
Axogen, Inc. (Nasdaq: AXGN) has completed its acquisition of BioCircuit Technologies. This acquisition includes NerveTape, which Axogen describes as the first FDA-cleared device for sutureless peripheral nerve repair.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.